Align technology announces $250 million accelerated stock repurchase agreement

Tempe, ariz.--( business wire )--align technology, inc. (“align”) (nasdaq: algn), a leading global medical device company that designs, manufactures, and sells the invisalign® system of clear aligners, itero™ intraoral scanners, and exocad™ cad/cam software for digital orthodontics and restorative dentistry, today announced that it has entered into a new accelerated stock repurchase agreement ("asr") with citibank, n.a. (“citi”), to repurchase $250 million of align's common stock under align's $1.0 billion stock repurchase program announced on may 13, 2021.
ALGN Ratings Summary
ALGN Quant Ranking